|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
28
|
|
pubmed:dateCreated |
2009-9-30
|
|
pubmed:databankReference |
|
|
pubmed:abstractText |
To determine the clinical utility of intrinsic molecular phenotype after breast-conserving therapy (BCT) with lumpectomy and whole-breast irradiation with or without a cavity boost.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Keratin-5,
http://linkedlifedata.com/resource/pubmed/chemical/Keratin-6,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor, Epidermal Growth Factor,
http://linkedlifedata.com/resource/pubmed/chemical/Receptor, erbB-2,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Estrogen,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Progesterone,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Markers, Biological
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
1527-7755
|
|
pubmed:author |
pubmed-author:BeretovJuliaJ,
pubmed-author:BrowneLoisL,
pubmed-author:CappAnneA,
pubmed-author:DelaneyGeoffG,
pubmed-author:EggletonSarahS,
pubmed-author:FoxChristopherC,
pubmed-author:GrahamPeter HPH,
pubmed-author:KearsleyJohn HJH,
pubmed-author:McNeilCatriona MCM,
pubmed-author:MillarEwan K AEK,
pubmed-author:MoreyAdrienne LAL,
pubmed-author:NasserEliasE,
pubmed-author:O'TooleSandra ASA,
pubmed-author:PapadatosGeorgeG,
pubmed-author:SutherlandRobert LRL,
pubmed-author:TheocharousConstantineC
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
1
|
|
pubmed:volume |
27
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
4701-8
|
|
pubmed:dateRevised |
2010-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:19720911-Adult,
pubmed-meshheading:19720911-Aged,
pubmed-meshheading:19720911-Aged, 80 and over,
pubmed-meshheading:19720911-Breast Neoplasms,
pubmed-meshheading:19720911-Combined Modality Therapy,
pubmed-meshheading:19720911-Female,
pubmed-meshheading:19720911-Humans,
pubmed-meshheading:19720911-Immunohistochemistry,
pubmed-meshheading:19720911-In Situ Hybridization, Fluorescence,
pubmed-meshheading:19720911-Kaplan-Meier Estimate,
pubmed-meshheading:19720911-Keratin-5,
pubmed-meshheading:19720911-Keratin-6,
pubmed-meshheading:19720911-Middle Aged,
pubmed-meshheading:19720911-Neoplasm Invasiveness,
pubmed-meshheading:19720911-Neoplasm Metastasis,
pubmed-meshheading:19720911-Neoplasm Recurrence, Local,
pubmed-meshheading:19720911-Neoplasm Staging,
pubmed-meshheading:19720911-Predictive Value of Tests,
pubmed-meshheading:19720911-Prognosis,
pubmed-meshheading:19720911-Receptor, Epidermal Growth Factor,
pubmed-meshheading:19720911-Receptor, erbB-2,
pubmed-meshheading:19720911-Receptors, Estrogen,
pubmed-meshheading:19720911-Receptors, Progesterone,
pubmed-meshheading:19720911-Tumor Markers, Biological,
pubmed-meshheading:19720911-Young Adult
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Prediction of local recurrence, distant metastases, and death after breast-conserving therapy in early-stage invasive breast cancer using a five-biomarker panel.
|
|
pubmed:affiliation |
Cancer Research Program, Garvan Institute of Medical Research, Darlinghurst, New South Wales 2010, Australia. e.millar@garvan.org.au
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
